TickerFactsScreenerDevelopers

BioRestorative Therapies, Inc. (BRTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$729.2K2011: -$2.81M2012: -$3.18M2017: -$3.85M2018: -$5.10M2019: -$6.92M2020: -$1.96M2021: -$3.33M2022: -$5.91M2023: -$6.43M2024: -$8.23M2025: -$10.79M-$10.79M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.79M-31.1%
2024-$8.23M-28.0%
2023-$6.43M-8.7%
2022-$5.91M-77.6%
2021-$3.33M-69.5%
2020-$1.96M+71.6%
2019-$6.92M-35.5%
2018-$5.10M-32.5%
2017-$3.85M—
2012-$3.18M-13.3%
2011-$2.81M-285.5%
2010-$729.2K—